CEFPODOXIME TEVA for children and for infants 40 mg/5 ml, powder for oral suspension bottle, 50 ml
Active ingredients: Cefpodoxime, Cefpodoxime proxetil
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral suspensionbottle, 50 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFPODOXIME TEVA ENFANTS ET NOURRISSONS 40 mg/5 mL, poudre pour suspension buvable
- Pharmaceutical form
- poudre pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 50 ml avec seringue(s) pour administration orale polyéthylène polystyrène avec gobelet(s) doseur(s) polypropylène
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Feb 2009
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67939013CIP73873332CIP133400938733327Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CEFPODOXIMEpoudre | 40 mg · 5 mL de suspension reconstituée | FT |
| CEFPODOXIME PROXÉTILpoudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.